Research I 20 October 2025
Best Poster Award at ESMO 2025!
The EuroACT project was featured Sunday 19th October 2025 at ESMO 2025 Congress showcasing our work on mapping the European clinical trial landscape.
We are proud to share that our poster received the Best Poster Award, recognising its outstanding clarity of presentation, rigorous methodology, and strong relevance to current oncology practice and policymaking.
The poster presentation highlighted:
- Visualising disparities across countries
- Identifying access challenges
- Equipping patient advocates, regulators, and industry with actionable evidence
This achievement marks another important step towards making clinical trial data more transparent and accessible and advancing equitable access to innovation across Europe.
You can download the poster here: DOWNLOAD POSTER IN PDF
Puga L, et al. European atlas on clinical trials in cancer and haematology (EuroACT): Mapping research and equity across Europe. Annals of Oncology. 2025;36(Suppl):S1184. doi:10.1016/j.annonc.2025.08.2925
ABOUT THE PROJECT
EuroACT is a research project initiated by WECAN and the European Hematology Community. The project aims to understand the clinical trial landscape in the European region, based on data extracted from all relevant European clinical trial registers. Data from the past five years will unveil differences where clinical trials have been run in European countries and will describe how and which patient-reported outcomes (PROs) and quality-of-life (QoL) instruments have been used in clinical trials.
